| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Apr―16 |
Prevalence and incidence of medication-treated diabetes and pattern of glucose-lowering treatment during the COVID-19 pandemic: real-world data from the electronic Greek prescription database |
Christos Siafarikas, Georgios Karamanakos, Konstantinos Makrilakis, Anastasios Tsolakidis, Konstantinos Mathioudakis, Stavros Liatis |
| 2 |
[GO] |
2023―Dec―05 |
Male Hypogonadism After Recovery from Acute COVID-19 Infection: A
Prospective Observational Study |
Aravind Prasad, K. G Rashmi, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Mukta Wyawahare, R Anusuya, Dukhabandhu Naik |
| 3 |
[GO] |
2023―Apr―04 |
Association between prehospital blood glucose levels and outcomes in patients with COVID-19 infection: a retrospective cohort study |
Christophe Fehlmann, Laurent Suppan, Christophe Gaudet-Blavignac, Nadia. Elia, Karim Gariani |
| 4 |
[GO] |
2023―Mar―28 |
Metabolic and endocrine complications of long COVID-19: A review |
Thushari Bandara, Harshal A Deshmukh, Mohammed Abdalla, Thozhukat Sathyapalan |
| 5 |
[GO] |
2023―Jan―24 |
Glucometabolic perturbations in type 2 diabetes mellitus and coronavirus disease 2019: causes, consequences, and how to counter them using novel antidiabetic drugs |
Djordje Popovic, NIKOLAOS PAPANAS, Theocharis Koufakis, Kalliopi Kotsa, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, Maciej Banach, Yajnavalka Banerjee, Antonio Ceriello, Mustafa Cesur, Francesco Cosentino, Alberto Firenze, Massimo Galia, Su-Yen Goh, A. Janez, Sanjay Kalra, Peter Kempler, Nitin Kapoor, Nader Lessan, Paulo Lotufo, Ali A Rizvi, Amirhossein Sahebkar, Raul D Santos, Anca Pantea Stoian, Peter P Toth, Vijay Viswanathan, Manfredi Rizzo |
| 6 |
[GO] |
2023―Jan―10 |
Fasting plasma glucose increase and Neutrophil to Lymphocyte Ratio (NLR) as risk predictors of clinical outcome of COVID-19 pneumonia in type 2 diabetes mellitus |
Vasileios Petrakis, Periklis Panagopoulos, Grigorios Trypsianis, Dimitrios Papazoglou, NIKOLAOS PAPANAS |
| 7 |
[GO] |
2022―Feb―19 |
COVID-19 Lockdown Periods in 2020: Good Maintenance of Metabolic
Control in Adults with Type 1 and Type 2 Diabetes |
B Hartmann, S R Tittel, M Femerling, M. Pfeifer, S. Meyhöfer, K Lange, S Milek, L Stemler, F Best, R W Holl |
| 8 |
[GO] |
2021―Nov―30 |
Glucose on Admission: Unfavourable Effects on Hospitalisation and
Outcomes in Type 2 Diabetes Mellitus Patients with COVID-19
Pneumonia |
Vasilios Petrakis, Periklis Panagopoulos, Grigorios Trypsianis, Dimitrios Papazoglou, Nikolaos Papanas |
| 9 |
[GO] |
2021―Aug―12 |
Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity) |
Ibrahim Sahin, Cem Haymana, Tevfik Demir, Ibrahim Demirci, Ilker Tasci, Aysegul Atmaca, Erman Cakal, Naim Ata, Rifat Emral, Ugur Unluturk, Derun Ertugrul, Serpil Salman, Mustafa Sahin, Selcuk Dagdelen, Osman Celik, Murat Caglayan, Ilhan Satman, Alper Sonmez |
| 10 |
[GO] |
2021―Jun―23 |
Diabetes Mellitus as the Major Factor of Prolonged Hospitalisation in Mild or Moderate COVID-19 Pneumonia |
Vasileios Petrakis, Grigorios Trypsianis, Periklis Panagopoulos, Dimitrios Papazoglou, Nikolaos Papanas |
| 11 |
[GO] |
2020―Dec―09 |
Diabetes Mellitus and Hypertension as Major Risk Factors of Mortality From Covid-19 Pneumonia |
Vasileios Petrakis, Periklis Panagopoulos, Dimitrios Papazoglou, Nikolaos Papanas |
| 12 |
[GO] |
2020―Nov―06 |
COVID-19 and Cardiovascular Comorbidities |
Dirk Müller-Wieland, Nikolaus Marx, Michael Dreher, Katharina Fritzen, Oliver Schnell |
| 13 |
[GO] |
2020―Sep―10 |
COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to
Attempt? |
Stella Papachristou, Theano Penlioglou, Anca Pantea Stoian, Nikolaos Papanas |
| 14 |
[GO] |
2020―Aug―07 |
Therapeutic Patient Education for Adrenal Insufficiency under
COVID-19 Pandemic Conditions |
Tina Kienitz, Stefanie Hahner, Stephanie Burger-Stritt, Marcus Quinkler |
|
